Royalty Pharma plc
RPRXHealthcare · Stock · quarterly payer
Forward Yield
1.60%
Annual Dividend
$0.94
Payout Ratio
47%
5-Yr Growth
8.0%
Ex-Date
Aug 14, 2026
Frequency
Quarterly
Summary
As of July 2026, Royalty Pharma plc (RPRX) yields 1.60% ($0.94 per share annually), with a blended fair-value estimate of $116.77 — +98% upside, so it screens as undervalued. Dividend safety grade: B (76/100). 5 years of dividend growth.
Is RPRX a good dividend stock?
YesRoyalty Pharma plc (RPRX) pays a quarterly dividend yielding 1.60% ($0.94/yr), with 5 years of growth and a dividend-safety grade of B. It scores well across payout coverage, growth history and safety — a dependable income holding.
Advantages
- Never cut its dividend on record
- Comfortable payout ratio (47%)
- Strong 8.0% 5-yr dividend growth
- 52% total price return over 5 years
Risks
- Single-stock concentration risk — diversify
Key Data
- Dividend Yield
- 1.60%
- Payout Ratio
- 47%
- Annual Dividend
- $0.94
- 5-Yr Avg Growth
- 8.0%
- Ex-Dividend Date
- Aug 14, 2026
- Years of Growth
- 5
- Frequency
- quarterly
- Beta
- 0.42
- Market Cap
- $33.9B
- P/E Ratio
- 31.0
- 5-Yr Total Return
- 52%
- 52-Week Range
- $34.08 – $59.72
- Dividend Safety
- B · 76/100
- Ever Cut?
- No
Frequently Asked Questions
RPRX Price — Last 12 Months
Daily close
Price Return
1 Year
+64%
3 Years
+97%
5 Years
+52%
52-Week Range
$34.08 – $59.72
Price change over each period (excludes dividends). Past performance doesn't guarantee future results.
What is RPRX worth?
Undervaluedlow confidenceOur blended fair-value estimate for Royalty Pharma plc is $116.77 per share, versus a market price of $58.83. That implies 98% of upside — a margin of safety of about 50%.
Fair Value
$116.77
Current Price
$58.83
Upside
+98%
Margin of Safety
50%
How we get there
Discounted cash flow
Discounts projected free cash flow back to today.
Dividend discount
Discounts the future dividend stream back to today.
Earnings multiple (Graham)
Graham's earnings-multiple formula, anchored to bond yields.
At today's price, the market is pricing in about -10.0% annual free-cash-flow growth. We model 13.1% — below our estimate, leaving room for upside if the business executes.
Assumptions: 7.0% discount rate (CAPM), 13.1% stage-1 growth, 2.5% terminal growth, $1.90 EPS, $0.94 annual dividend. Updated weekly.
Fair-value estimates are model output for educational purposes only — not investment advice or a price target.
RPRX Dividend Safety Score
Safe
SmarterDividends' proprietary score, backtested against which dividends were actually cut over 15+ years (0.78 AUC). It blends a validated cut-risk model (growth streak, cut history) with current payout, cash-flow and debt. Higher is safer · not investment advice.
Dividend Growth
Total dividends per share by year
Dividend History
| Ex-Date | Pay Date | Amount | Type |
|---|---|---|---|
| May 15, 2026 | — | $0.2350 | regular |
| Feb 20, 2026 | — | $0.2350 | regular |
| Nov 14, 2025 | — | $0.2200 | regular |
| Aug 15, 2025 | — | $0.2200 | regular |
| May 16, 2025 | — | $0.2200 | regular |
| Feb 21, 2025 | — | $0.2200 | regular |
| Nov 15, 2024 | — | $0.2100 | regular |
| Aug 16, 2024 | — | $0.2100 | regular |
| May 16, 2024 | — | $0.2100 | regular |
| Feb 15, 2024 | — | $0.2100 | regular |
| Nov 16, 2023 | — | $0.2000 | regular |
| Aug 17, 2023 | — | $0.2000 | regular |
| May 18, 2023 | — | $0.2000 | regular |
| Feb 15, 2023 | — | $0.2000 | regular |
Income Calculator
At $0.94 / yr per share
